TECTONIC THERAPEUTIC, INC. Accrued Professional Fees, Current
TECTONIC THERAPEUTIC, INC. (TECX) had Accrued Professional Fees, Current of $803.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Professional Fees, Current $803.00K.
- 2026-03-31: Accrued Professional Fees, Current $1.10M.
- 2025-12-31: Accrued Professional Fees, Current $929.00K.
- 2025-09-30: Accrued Professional Fees, Current $1.43M.
| Period end | Accrued Professional Fees, Current | Accrued Professional Fees, Current as first filed |
|---|---|---|
| 2026-06-30 | $803.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $929.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.43M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.45M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.90M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.48M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.93M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.61M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.63M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.07M 10-K · filed 2025-03-20 | $892.00K 10-K · filed 2024-03-14 |
| 2023-09-30 | $1.12M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $375.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.18M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $871.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $771.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $978.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $999.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $889.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $897.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $942.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.10M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $1.03M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $144.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $974.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $917.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $850.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $401.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $484.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $320.00K 10-K · filed 2020-03-16 | |
| 2017-12-31 | $267.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |